Research theme for competitive and other funds (23)：
2021 - 2027 How to better understand the pathophysiology of neurodevelopmental disorders associated with low-birthweight and to prevent them with cell therapies and lactoferrin
2022 - 2025 SGA児の低酸素性虚血性脳症における重症化機序解明とMuse細胞療法の研究
2021 - 2024 A Study of Neonatal Respiration and Heartbeat Measuring Method Using Doppler Sensor
2019 - 2022 Development of a novel treatment for neonatal/children with pulmonary hypertension
2019 - 2022 Elucidation of severe mechanism and development of novel therapy against chronic lung disease in SGA infants caused by pregnancy induced hypertension
2017 - 2020 Development of a novel two-step cell therapy for perinatal hypoxic ischemic encephalopathy
2016 - 2019 The development of cell therapies for complications in several organs in infants with CLD
2016 - 2019 Development of a novel treatment for neonatal chronic lung disease by stem cells
2015 - 2018 Development of novel therapy for chronic lung disease associated pulmonary arterial hypertension via proliferation of pulmonary alveoli.
2014 - 2017 Stem cell therapy for brain injuries of infants with fetal growth restriction
2014 - 2017 Development of a novel therapy for perinatal brain injury with dedifferentiated fat cells
2013 - 2017 Transplantation of rat umbilical cord blood cells for neonatal hypoxic-ischemic brain injury.
2012 - 2015 The role of perivascular sympathetic nerve in the development of experimental pulmonary arterial hypertension and the effect of endothelin on vascular innervation
2012 - 2015 Umbilical cord blood cell therapies in a novel neonatal stroke model
2012 - 2015 Developing a novel therapy with mesenchymal stem cells which suppress CCL2 for perinatal brain injuries
2011 - 2013 The study of the neurological effects of GH therapy for SGA rats
2011 - 2013 Developing a novel therapy with bone marrow mononuclear cells for perinatal brain injuries
2009 - 2010 Developing a novel therapy with umbilical cord blood cells for perinatal brain injuries
2008 - 2010 A research of nutritional strategies to prevent metabolic syndrome in patients with fetal growth restriction
2007 - 2009 Analyses of reduced brain injury by treatment with neural stem /progenitor cells together with chondroitinase.
Show all
Papers (121)：
Akinobu Taniguchi, Kazuki Nishida, Toshihiko Suzuki, Erina Kataoka, Naozumi Fujishiro, Eiko Kato, Hikaru Yamamoto, Koji Takemoto, Miharu Ito, Seiji Hayashi, et al. Total Hydrocortisone Dosage in the Neonatal Period May Be Related to Low Developmental Quotient in Extremely Low Birth Weight Infants: A Retrospective Cohort Study. Neonatology. 2023. 1-8
Takafumi Ushida, Masahiro Nakatochi, Yumiko Kobayashi, Noriyuki Nakamura, Kazuya Fuma, Yukako Iitani, Kenji Imai, Yoshiaki Sato, Masahiro Hayakawa, Hiroaki Kajiyama, et al. Antenatal corticosteroids and outcomes of small for gestational age infants born at 24-31 gestational weeks: a population-based propensity score matching analysis. Archives of gynecology and obstetrics. 2023. 308. 5. 1463-1471
THE JAPAN NEUROSCIENCE SOCIETY
, THE JAPANESE SOCIETY FOR REGENERATIVE MEDICINE
, JAPAN SOCIETY FOR NEONATAL HEALTH AND DEVELOPMENT
, JAPAN SOCIETY OF PERINATAL AND NEONATAL MEDICINE
, JAPAN PEDIATRIC SOCIETY
